| 51 |
14514687 | The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis. | 2003 Dec 12 |
1 |
| 52 |
14529677 | Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. | 2003 Oct |
1 |
| 53 |
12121974 | Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. | 2002 Sep 20 |
2 |
| 54 |
11160861 | Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. | 2001 Feb |
5 |
| 55 |
11245462 | Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. | 2001 Feb 15 |
1 |
| 56 |
11278851 | Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery. | 2001 Jun 1 |
2 |
| 57 |
11425893 | Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation. | 2001 Jul 1 |
7 |
| 58 |
11461094 | Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. | 2001 Jul 20 |
3 |
| 59 |
11598801 | ASK1 resistant neuroblastoma is deficient in activation of p38 kinase. | 2001 Oct |
1 |
| 60 |
10623471 | Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. | 2000 Jan 10 |
1 |
| 61 |
10823417 | Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism. | 2000 May |
1 |
| 62 |
10861441 | Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. | 2000 Jun 1 |
1 |
| 63 |
10976921 | Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. | 2000 Sep |
5 |
| 64 |
11038347 | MEK inhibition enhances paclitaxel-induced tumor apoptosis. | 2000 Dec 15 |
1 |
| 65 |
9927194 | Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. | 1999 Jan 14 |
3 |
| 66 |
10075725 | Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. | 1999 Mar 19 |
11 |
| 67 |
10097113 | Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. | 1999 Mar 30 |
3 |
| 68 |
10196170 | Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents. | 1999 Apr 16 |
1 |
| 69 |
10212239 | MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. | 1999 Apr 30 |
2 |
| 70 |
9443400 | Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. | 1998 Jan 15 |
2 |
| 71 |
9478937 | Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. | 1998 Feb 27 |
2 |
| 72 |
9774447 | Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). | 1998 Oct 23 |
8 |